Sumitomo Pharma Co., Ltd. (TYO: 4506)

Sumitomo Pharma Revenue

Sumitomo Pharma had revenue of 90.07B JPY in the quarter ending September 30, 2024, with 17.05% growth. This brings the company's revenue in the last twelve months to 342.67B, down -11.89% year-over-year. In the fiscal year ending March 31, 2024, Sumitomo Pharma had annual revenue of 314.56B, down -43.38%.

• Revenue (ttm): 342.67B
• Revenue Growth: -11.89%
• P/S Ratio: 0.71
• Revenue / Employee: 68.81M
• Employees: 4,980
• Market Cap: 242.74B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2024	314.56B	-240.99B	-43.38%
Mar 31, 2023	555.54B	-4.49B	-0.80%
Mar 31, 2022	560.04B	44.08B	8.54%
Mar 31, 2021	515.95B	33.22B	6.88%
Mar 31, 2020	482.73B	23.47B	5.11%